CO6511276A2 - Composición probiótica para uso en el tratamiento de la inflamación del intestino - Google Patents
Composición probiótica para uso en el tratamiento de la inflamación del intestinoInfo
- Publication number
- CO6511276A2 CO6511276A2 CO12125095A CO12125095A CO6511276A2 CO 6511276 A2 CO6511276 A2 CO 6511276A2 CO 12125095 A CO12125095 A CO 12125095A CO 12125095 A CO12125095 A CO 12125095A CO 6511276 A2 CO6511276 A2 CO 6511276A2
- Authority
- CO
- Colombia
- Prior art keywords
- treatment
- intestine
- inflammation
- probiotic composition
- cect
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 210000000936 intestine Anatomy 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
- 240000006024 Lactobacillus plantarum Species 0.000 abstract 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 abstract 2
- 229940072205 lactobacillus plantarum Drugs 0.000 abstract 2
- 206010000060 Abdominal distension Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 241000191998 Pediococcus acidilactici Species 0.000 abstract 1
- 208000020560 abdominal swelling Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/41—Pediococcus
- A23V2400/413—Acidilactici
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29911610P | 2010-01-28 | 2010-01-28 | |
| EP10151998 | 2010-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6511276A2 true CO6511276A2 (es) | 2012-08-31 |
Family
ID=42243204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO12125095A CO6511276A2 (es) | 2010-01-28 | 2012-07-25 | Composición probiótica para uso en el tratamiento de la inflamación del intestino |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20130101566A1 (enExample) |
| EP (1) | EP2528610B1 (enExample) |
| JP (1) | JP5777640B2 (enExample) |
| KR (1) | KR101840239B1 (enExample) |
| CN (1) | CN102905712B (enExample) |
| AU (1) | AU2011209407B2 (enExample) |
| BR (1) | BR112012018813B1 (enExample) |
| CA (1) | CA2787544C (enExample) |
| CL (1) | CL2012002062A1 (enExample) |
| CO (1) | CO6511276A2 (enExample) |
| ES (1) | ES2437940T3 (enExample) |
| MX (1) | MX2012008817A (enExample) |
| MY (1) | MY162344A (enExample) |
| PH (1) | PH12012501540A1 (enExample) |
| PL (1) | PL2528610T3 (enExample) |
| RU (1) | RU2563525C2 (enExample) |
| UA (1) | UA109123C2 (enExample) |
| WO (1) | WO2011092261A1 (enExample) |
| ZA (1) | ZA201205683B (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9579353B2 (en) * | 2011-06-10 | 2017-02-28 | Prothera, Inc. | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
| WO2012169842A2 (ko) * | 2011-06-10 | 2012-12-13 | (주)아모레퍼시픽 | 차나무 잎에서 분리한 신규 락토바실러스 플란타룸 |
| JP5995593B2 (ja) * | 2012-08-02 | 2016-09-21 | 丸善製薬株式会社 | 抗炎症剤 |
| WO2014096901A1 (en) * | 2012-12-18 | 2014-06-26 | Compagnie Gervais Danone | Strain of bifidobacterium animalis ssp. animalis |
| CN105263343B (zh) * | 2013-04-08 | 2019-03-08 | N·V·努特里奇亚 | 含有巯基蛋白酶抑制剂的发酵营养组合物 |
| SI24570A (sl) | 2013-12-23 | 2015-06-30 | Medis D.O.O. | Novi sevi rodu Lactobacillus in njihova uporaba |
| HK1225637A1 (zh) * | 2014-02-28 | 2017-09-15 | 株式会社明治 | 功能性消化道障碍预防和/或改善剂 |
| US10967013B2 (en) * | 2014-04-23 | 2021-04-06 | National Yang-Ming University | Lactic acid bacterium for prophylaxis or treatment of a stress-induced disorder and a composition containing the same |
| US10188684B2 (en) * | 2015-04-20 | 2019-01-29 | National Yang-Ming University | Method for preventing or treating functional gastrointestinal disorder by lactic acid bacterium |
| WO2016083450A2 (en) * | 2014-11-25 | 2016-06-02 | Stichting Top Institute Food And Nutrition | New probiotic and new biomarker |
| BR112017011078B1 (pt) * | 2014-11-28 | 2021-05-11 | Anagenix Ip Limited | usos de uma composição preparada a partir de kiwi ouro seco |
| US10195237B2 (en) * | 2015-03-16 | 2019-02-05 | Imagilin Technology Llc | Compositions and methods for treating inflammatory related diseases or conditions using Pediococcus acidilactici probiotics |
| US10946050B2 (en) | 2015-03-16 | 2021-03-16 | Imagilin Technology Llc | Compositions comprising probiotics and methods of use thereof |
| MA41010B1 (fr) * | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| US10857190B2 (en) | 2015-10-06 | 2020-12-08 | Albert Einstein College Of Medicine | Microbial hyperswarmers and uses thereof |
| RU2752157C2 (ru) | 2017-01-31 | 2021-07-23 | Юниверсити-Индастри Кооперейшн Груп Оф Кюн Хее Юниверсити | Новые молочнокислые бактерии и их применение |
| KR102464397B1 (ko) * | 2017-09-15 | 2022-11-08 | (주)아모레퍼시픽 | 락토바실러스 플란타룸을 포함하는 위장관 질환의 예방 및 개선용 조성물 |
| MX420836B (es) * | 2018-02-02 | 2025-02-10 | Kobiolabs Inc | Cepa lactobacillus plantarum kbl396 y uso de la misma. |
| US11504408B2 (en) * | 2018-03-15 | 2022-11-22 | University Of Southern California | Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology |
| AR115757A1 (es) * | 2018-07-13 | 2021-02-24 | Cj Cheiljedang Corp | Composición que comprende la cepa cjlp475 de lactobacillus plantarum y la cepa cjlp17 de lactobacillus plantarum y el uso de la misma |
| KR102118343B1 (ko) * | 2018-07-13 | 2020-06-03 | 롯데푸드 주식회사 | 장 도달력이 우수하고 장내 염증 예방 효과를 가지는 우유와 발효유 |
| KR102036275B1 (ko) * | 2018-10-02 | 2019-10-24 | 서울대학교 산학협력단 | 항-염증 활성이 우수한 페디오코커스 악시딜락티시 ldtm 5201 신균주(kctc 13563bp) |
| KR102038695B1 (ko) * | 2018-10-30 | 2019-10-30 | 주식회사 종근당바이오 | 프로바이오틱스를 유효성분으로 포함하는 알코올성 장손상 예방 또는 치료용 조성물 |
| US20220054561A1 (en) * | 2018-12-14 | 2022-02-24 | The University Of North Carolina At Chapel Hill | Lachnospiraceae mitigates against radiation-induced hematopoietic/gastrointestinal injury and death, and promotes cancer control by radiation |
| KR102094415B1 (ko) * | 2018-12-17 | 2020-03-30 | 강원대학교산학협력단 | 프로바이오틱 활성 및 항균활성을 갖는 페디오코커스 애시디락티시 균주 |
| WO2021125822A1 (ko) * | 2019-12-17 | 2021-06-24 | 한국 한의학 연구원 | 페디오코쿠스 이노피나투스를 유효성분으로 포함하는 숙취해소용 조성물 |
| WO2022171304A1 (en) * | 2021-02-12 | 2022-08-18 | Ab-Biotics, S.A. | Probiotic composition for the treatment of covid-19 |
| JPWO2023176849A1 (enExample) | 2022-03-17 | 2023-09-21 | ||
| CN114921351B (zh) * | 2022-05-06 | 2023-06-13 | 大连工业大学 | 一株具有益生功能的毕赤酵母菌dpuy-f1及在缓解结肠炎症状中的应用 |
| CN116083277B (zh) * | 2022-09-17 | 2024-02-13 | 浙江大学 | 具有缓解溃疡性结肠炎功效的乳酸片球菌zjuids13及其应用 |
| KR20240102112A (ko) * | 2022-12-23 | 2024-07-03 | 주식회사 씨티씨바이오 | 대장염 예방 또는 치료활성 및 장내 유해균에 항균활성을 지닌 락토바실러스 및 그의 용도 |
| KR102803865B1 (ko) * | 2023-07-31 | 2025-05-09 | 전라남도 | 사료첨가제 및 이를 포함하는 사료 조성물 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE463796B (sv) | 1988-03-09 | 1991-01-28 | Carl Erik Albertsson | Foerfarande foer framstaellning av en naeringskomposition och daervid framstaelld naeringskomposition |
| SE469875C (sv) | 1991-07-25 | 1997-04-14 | Probi Ab | Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen |
| SE9501056D0 (sv) | 1995-03-23 | 1995-03-23 | Probi Ab | Epithelial adherent lactobacilli |
| ID29150A (id) | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
| FR2813790B1 (fr) * | 2000-09-11 | 2004-03-12 | Dolisos Lab | Preparations pharmaceutiques contenant des extraits d'isoflavone de soja et des micro-organismes probiotiques |
| EP1384483A1 (en) * | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
| EP1633378A2 (en) * | 2003-06-13 | 2006-03-15 | N.V. Nutricia | Pediocin-producing pediococci |
| KR101095712B1 (ko) * | 2003-08-21 | 2011-12-20 | 오츠카 세이야쿠 가부시키가이샤 | 점막 면역 부활 작용을 갖는 유산균 |
| EP1714660A1 (en) * | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Uronic acid and probiotics |
| AT501919B1 (de) * | 2005-06-14 | 2008-09-15 | Erber Ag | Probiotischer, gesundheits- bzw. leistungsfördernder futtermittel- und/oder trinkwasserzusatz für tiere sowie seine verwendung |
| SI1951272T1 (sl) * | 2005-10-06 | 2016-10-28 | Probi Ab | Uporaba lactobacillus za zdravljenje virusnih infekcij |
| DE602006017423D1 (de) * | 2005-11-14 | 2010-11-18 | Unilever Nv | Essbares produkt, das ginseng-polysaccharide und gesunde bakterien enthält |
| US20070298013A1 (en) * | 2006-06-23 | 2007-12-27 | Altman Jay A | Animal Nutritional Supplement and Method |
| JP2008013534A (ja) * | 2006-07-07 | 2008-01-24 | Health Vision:Kk | ペット用プロバイオティクス製品 |
| CN102006788A (zh) * | 2008-03-14 | 2011-04-06 | 雀巢产品技术援助有限公司 | 合益素混合物 |
| WO2010114864A1 (en) * | 2009-04-01 | 2010-10-07 | Little Calumet Holdings, Llc | Probiotic oral dosage forms |
| US8298526B2 (en) * | 2010-06-02 | 2012-10-30 | Genmont Biotech Inc. | Lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof |
| WO2015021530A1 (en) * | 2013-08-12 | 2015-02-19 | Mansel Griffiths | Antiviral methods and compositions comprising probiotic bacterial molecules |
-
2011
- 2011-01-27 CA CA2787544A patent/CA2787544C/en active Active
- 2011-01-27 UA UAA201210207A patent/UA109123C2/ru unknown
- 2011-01-27 RU RU2012136615/10A patent/RU2563525C2/ru active
- 2011-01-27 AU AU2011209407A patent/AU2011209407B2/en active Active
- 2011-01-27 US US13/575,865 patent/US20130101566A1/en not_active Abandoned
- 2011-01-27 MY MYPI2012003332A patent/MY162344A/en unknown
- 2011-01-27 CN CN201180007399.0A patent/CN102905712B/zh active Active
- 2011-01-27 MX MX2012008817A patent/MX2012008817A/es active IP Right Grant
- 2011-01-27 KR KR1020127021713A patent/KR101840239B1/ko active Active
- 2011-01-27 EP EP11702426.5A patent/EP2528610B1/en active Active
- 2011-01-27 PH PH1/2012/501540A patent/PH12012501540A1/en unknown
- 2011-01-27 JP JP2012550449A patent/JP5777640B2/ja active Active
- 2011-01-27 BR BR112012018813-5A patent/BR112012018813B1/pt active IP Right Grant
- 2011-01-27 WO PCT/EP2011/051170 patent/WO2011092261A1/en not_active Ceased
- 2011-01-27 ES ES11702426.5T patent/ES2437940T3/es active Active
- 2011-01-27 PL PL11702426T patent/PL2528610T3/pl unknown
-
2012
- 2012-07-25 CO CO12125095A patent/CO6511276A2/es unknown
- 2012-07-25 CL CL2012002062A patent/CL2012002062A1/es unknown
- 2012-07-27 ZA ZA2012/05683A patent/ZA201205683B/en unknown
-
2016
- 2016-04-21 US US15/134,558 patent/US10155015B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL2528610T3 (pl) | 2014-02-28 |
| WO2011092261A1 (en) | 2011-08-04 |
| CA2787544A1 (en) | 2011-08-04 |
| MX2012008817A (es) | 2012-11-23 |
| UA109123C2 (uk) | 2015-07-27 |
| US10155015B2 (en) | 2018-12-18 |
| CN102905712A (zh) | 2013-01-30 |
| EP2528610B1 (en) | 2013-11-13 |
| JP5777640B2 (ja) | 2015-09-09 |
| AU2011209407B2 (en) | 2014-02-27 |
| AU2011209407A1 (en) | 2012-09-20 |
| KR20130002372A (ko) | 2013-01-08 |
| PH12012501540A1 (en) | 2012-10-22 |
| KR101840239B1 (ko) | 2018-03-20 |
| BR112012018813B1 (pt) | 2020-12-08 |
| ES2437940T3 (es) | 2014-01-15 |
| EP2528610A1 (en) | 2012-12-05 |
| RU2012136615A (ru) | 2014-03-10 |
| US20130101566A1 (en) | 2013-04-25 |
| RU2563525C2 (ru) | 2015-09-20 |
| BR112012018813A2 (pt) | 2017-06-20 |
| US20160220620A1 (en) | 2016-08-04 |
| ZA201205683B (en) | 2013-08-28 |
| MY162344A (en) | 2017-06-15 |
| JP2013517784A (ja) | 2013-05-20 |
| CL2012002062A1 (es) | 2013-10-04 |
| CA2787544C (en) | 2019-07-09 |
| CN102905712B (zh) | 2015-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6511276A2 (es) | Composición probiótica para uso en el tratamiento de la inflamación del intestino | |
| WO2015047941A3 (en) | Compositions and methods for treatment and prophylaxis of gastrointestinal diseases | |
| RU2008136876A (ru) | Применение bifidobacterium longum для предупреждения и лечения воспаления | |
| PH12013500441A1 (en) | Materials and methods for improving gastrointestinal function | |
| IL220613B (en) | Use of antibiotics and a probiotic formulation in the preparation of a drug for the treatment of inflammatory bowel disease | |
| EA201690147A1 (ru) | Пероральные композиции | |
| IN2012DN01638A (enExample) | ||
| CL2011001692A1 (es) | Composicion farmaceutica que entrega acido butirico y glutamina directamente en el colon, para inducir la liberacion de una hormona intestinal desde celulas l del colon; su uso en diabetes tipo i o tipo ii y obesidad, entre otros. | |
| MX379226B (es) | Composiciones y métodos para tratar trastornos metabólicos. | |
| WO2012047631A3 (en) | Compositions and methods useful for the treatment and diagnosis of inflammatory bowel disease | |
| HN2011003011A (es) | Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas | |
| BRPI0906492A2 (pt) | antagonistas da caderina-11 e métodos para o tratamento de doenças inflamatórias das articulações | |
| CL2011001939A1 (es) | Uso de lactobacillus helveticus cncm i-4095 para apoyar la perdida de peso y/o mantenimiento del peso en humanos y/o animales, particularmente para tratar la obesidad y trastornos metabólicos; y microorganismo de la cepa de lactobacillus helveticus cncm i-4095. | |
| UA113399C2 (xx) | Штам непатогенної грамнегативної бактерії та його застосування в дерматології | |
| CL2016000820A1 (es) | Diagnóstico y tratamiento del síndrome del intestino irritable y la enfermedad inflamatoria intestinal | |
| PL2457576T3 (pl) | Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji | |
| EA201291440A1 (ru) | Пробиотические штаммы для применения при повышении трансэпителиального сопротивления | |
| ES2711427T8 (es) | Lactobacillus reuteri ATCC PTA 6475 para su uso en la prevención o el tratamiento de la pérdida ósea en mamíferos | |
| CL2011001937A1 (es) | Uso de la cepa de lactobacillus rhamnosus cncm i-4096 para apoyar la pérdida de peso y/o mantenimiento del peso en humanos y/o animales, específicamente para el tratamiento de la obesidad. | |
| MX380752B (es) | Probiótico para el llanto infantil excesivo. | |
| WO2014011564A3 (en) | Compositions and method for treatment and prophylaxis of inflammatory bowel disease | |
| EP2730287A4 (en) | USE OF A SALMONELLA FLAGELLIN DERIVATIVE IN THE PREPARATION OF A MEDICAMENT FOR PREVENTING AND TREATING INFLAMMATORY INTESTINAL DISEASES | |
| MX2020009196A (es) | Combinacion de lactobacilos para el alivio del sindrome del intestino irritable y para el alivio de otros trastornos gastrointestinales. | |
| CL2009000878A1 (es) | Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como dolor, migraña, diabetes, enfermedades del tracto respiratorio, enfermedades intestinales inflamatorias, obesidad, entre otras. | |
| EP2488198A4 (en) | Treatment and diagnosis of inflammatory disorders |